Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06487936 · ClinicalTrials.gov registry record
Real-World Registry Study on Patient Satisfaction With TransLoc 3D SI Joint Fusion
A clinical trial of Sacroiliac Joint Dysfunction and Sacroiliac; Fusion, sponsored by CornerLoc.
- Recruiting
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT06487936: Recruiting study of Sacroiliac Joint Dysfunction and Sacroiliac; Fusion, sponsored by CornerLoc.
NCT06487936 is a study of Sacroiliac Joint Dysfunction and Sacroiliac; Fusion that is actively recruiting participants, run by CornerLoc. The registered enrollment target is 120 participants, below the 173-participant average among 3 other Sacroiliac Joint Dysfunction trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06487936, a study of Sacroiliac Joint Dysfunction and Sacroiliac; Fusion, is actively recruiting participants, sponsored by CornerLoc.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a multi-center, consecutive enrollment registry study to evaluate patient satisfaction post SI Fusion with the TransLoc 3D SI Fusion System.
Conditions Studied
Interventions
- DEVICE TransLoc 3D SI Joint Fusion System
Study Locations (1)
Florida
- Advanced Orthopedic Center - Port Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-08-15 |
| Est. Completion | 2024-12-15 |
What NCT06487936 shows while recruiting
NCT06487936 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 173-participant average among 3 other Sacroiliac Joint Dysfunction trials with a reported enrollment target (31% lower).
The record links to 2 conditions, with Sacroiliac Joint Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which TransLoc 3D SI Joint Fusion System is the first listed.
NCT06487936 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06487936 about?
NCT06487936 is a clinical study titled "Real-World Registry Study on Patient Satisfaction With TransLoc 3D SI Joint Fusion". This is a multi-center, consecutive enrollment registry study to evaluate patient satisfaction post SI Fusion with the TransLoc 3D SI Fusion System.
What is the current status of trial NCT06487936?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2024-08-15. Estimated completion is 2024-12-15.
What conditions does trial NCT06487936 study?
This clinical trial studies the following conditions: Sacroiliac Joint Dysfunction, Sacroiliac; Fusion.
What interventions are being tested in trial NCT06487936?
The interventions under investigation include: TransLoc 3D SI Joint Fusion System (DEVICE).
Who is sponsoring clinical trial NCT06487936?
This trial is sponsored by CornerLoc, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06487936 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sacroiliac Joint Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI